MedPath

Weight Loss Prior Mamma Reduction - A Pilot Study

Not Applicable
Completed
Conditions
Weight Loss
Hypertrophy
Interventions
Dietary Supplement: Low energy diet
Registration Number
NCT02659371
Lead Sponsor
Copenhagen University Hospital at Herlev
Brief Summary

Due to a higher risk of complications, obese and overweight patients with macromastia are in Denmark prohibited mammoplasty , as BMI must be within normal range, i.e. BMI \< 25 kg/m2.

The study is a pilot study with a diet intervention group and no control group. The intervention is a 12 week low energy diet pre-operative weight loss program investigating if this will result in weight loss making the overweight and obese patients eligible for breast reduction surgery i.e. BMI \< 25.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
6
Inclusion Criteria
  • entitled to mammoplasty,
  • motivated towards participation in a weight loss program
  • BMI within the range 25.5 to 35 kg/m2
Exclusion Criteria
  • more than 65 years of age
  • insulin-dependent diabetes
  • chronic heart, liver or kidney failure

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Low energy dietLow energy dietLow energy diet (800 kcal/d) for eight weeks, following 4 weeks on reintroduction supplying 1200 kcal/d.
Primary Outcome Measures
NameTimeMethod
Weight loss12 weeks

Measurement of weight to nearest 0.1 kg on category III approved body weight

Secondary Outcome Measures
NameTimeMethod
Pain and discomfort12 weeks

Questionnaire on pain in head, neck, shoulders

Breast size12 weeks

anthropometric measurements of the breasts by measuring tape.

Breast volumen12 weeks

measure of breast volumen

Trial Locations

Locations (1)

Copenhagen University Hospital at Herlev (EFFECT)

🇩🇰

Herlev, Denmark

© Copyright 2025. All Rights Reserved by MedPath